Sio Gene Therapies Inc (SIOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2017 | 03-2016 | 03-2015 | 03-2007 | |
| Operating Expenses | 180,499 | 133,162 | 0 | 0 |
| Operating Income | -180,499 | -133,162 | N/A | N/A |
| Interest Expense | 1,143 | 0 | 0 | 0 |
| Other Income | -369 | 0 | 0 | 0 |
| Pre-tax Income | -182,011 | -133,162 | 0 | 0 |
| Income Tax | -1,060 | -17 | 0 | N/A |
| Net Income Continuous | -180,951 | -133,145 | N/A | N/A |
| Net Income | $-180,951 | $-133,145 | $0 | $N/A |
| EPS Basic Total Ops | -14.56 | -11.28 | N/A | N/A |
| EPS Basic Continuous Ops | -14.60 | -11.28 | N/A | N/A |
| EPS Diluted Total Ops | -14.56 | -11.28 | N/A | N/A |
| EPS Diluted Continuous Ops | -14.60 | -11.28 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -14.56 | N/A | N/A | N/A |
| EBITDA(a) | $-180,250 | $-133,148 | $N/A | $N/A |